Altimmune Announces Positive Interim Data from ALT-801 Phase 1 Trial in Overweight and Obese VolunteersGlobeNewsWire • 06/16/21
Alternus Energy buys 60% stake in Netherlands-based clean energy group Unisun Energy Holding B.VProactive Investors • 06/03/21
Altimmune's Intranasal COVID-19 Vaccine Candidate Neutralizes South African Variant, Animal Study ShowsBenzinga • 05/26/21
Do Options Traders Know Something About Altimmune (ALT) Stock We Don't?Zacks Investment Research • 05/25/21
Altimmune: Q2 2021 Holds Large Upside Potential With 3 Trial Data Readouts And BARDA DecisionSeeking Alpha • 05/24/21
Altimmune, Inc.'s (ALT) CEO Vipin Garg on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/17/21
Altimmune Announces First Quarter 2021 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 05/17/21
Altimmune's Intranasal COVID-19 Vaccine Candidate Shows Sterilizing Immunity After Single DoseBenzinga • 05/10/21
Altimmune Announces New Preclinical Data for AdCOVID™ Demonstrating Sterilizing Immunity After a Single Intranasal DoseGlobeNewsWire • 05/10/21
Earnings Preview: Altimmune, Inc. (ALT) Q1 Earnings Expected to DeclineZacks Investment Research • 05/05/21
Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?The Motley Fool • 04/10/21
Altimmune's Anthrax Vaccine Candidate Shows Early Safety, Immunogenicity In Healthy VolunteersBenzinga • 04/01/21
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine CandidateGlobeNewsWire • 03/22/21
Altimmune's Shares Are Trading Higher On Intranasal COVID-19 Vaccine Candidate's Promising Action In Animal StudiesBenzinga • 03/15/21
Alternus Energy shows turn to positive EBITDA and strong revenue growth in financial results for year ended December 31, 2020Proactive Investors • 03/10/21